Deepak Bararia, PhD^1*, Michael Heide^1*, Robert S. Welner, PhD^2*, Tatiana Romashova^1*, Alessandro Pastore, MD^3*, Radhika Mathur^4*, Randy D. Gascoyne⁵, Robert Kridel, MD, MPH⁶, Boris G. Willson, PhD^7*, Charles W.M. Roberts, MD, PhD^4*, Wolfgang Hiddemann, MD, PhD^1*, David M Weinstock, MD⁸ and Oliver Weigert, MD¹

¹Department of Internal Medicine III, Ludwig-Maximilians University of Munich, Munich, Germany
²Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁵British Columbia Cancer Agency, Vancouver, BC, Canada
⁶Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
⁷Molecular Medicine Unit, Oncology R&D, GlaxoSmithKline, Collegeville, PA
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Makoto Yamagishi, Ph.D.^1*, Dai Fujikawa^1*, Daisuke Honma, Ph.D.^2*, Nobuaki Adachi, Ph.D.^2*, Shota Nakagawa^1*, Makoto Hori^1*, Naoya Kurokawa^1*, Ai Soejima^1*, Kazumi Nakano, Ph.D.^1*, Tadanori Yamochi, Ph.D.^1*, Makoto Nakashima^1*, Seiichiro Kobayashi, M.D., Ph.D.³, Yuetsu Tanaka, M.D., Ph.D.^4*, Masako Iwanaga, M.D., Ph.D.⁵, Atae Utsunomiya, M.D., Ph.D.⁶, Kaoru Uchimaru, M.D., Ph.D.^3*, Kunihiro Tsukasaki, M.D., Ph.D.⁷, Kazushi Araki, D.V.M., Ph.D.^2* and Toshiki Watanabe, M.D., Ph.D.^1*

¹Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
²Oncology Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan
³The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
⁴Graduate School and Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
⁵Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
⁶Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan
⁷Department of Hematology and Oncology, National Cancer Center Hospital East, Chiba, Japan

Teresa Palomero, PhD^1,2, Ana Carolina da Silva Almeida, PhD^2*, Francesco Abate, PhD^3*, Hossein Khiabanian, PhD^3*, Estela Martinez-Escala, MD^4*, Joan Guitart, MD^4*, Cornelis P. Tensen, MD^5*, Maarten H. Vermeer, MD, PhD^5*, Raul Rabadan, PhD^3* and Adolfo A. Ferrando, MD, PhD^1,2,6

¹Department of Pathology, Columbia University, New York, NY
²Institute for Cancer Genetics, Columbia University, New York, NY
³Department of Biomedical Informatics, Columbia University, New York, NY
⁴Department of Dermatology and Pathology, Northwestern University Feinberg Medical School, Chicago, IL
⁵Department of Dermatology, Leiden University Medical Center, Leiden, Netherlands
⁶Department of Pediatrics, Columbia University, New York, NY

Todd A Fehniger, MD, PhD, Kilannin Krysiak, PhD, Brian S White, PhD^*, Matthew Matlock^*, Chris Miller^*, Robert Fulton, PhD^*, Friederike Kreisel, MD, Catrina Fronick^*, Lisa Cook^*, Joelle Veizer^*, Amanda F. Cashen, MD, Kenneth R Carson, MD, PhD, Melissa M Berrien-Elliott, PhD^*, Nancy L Bartlett, MD, Richard K Wilson, PhD^*, Elaine R Mardis, PhD^*, Timothy J Ley, Malachi Griffith^* and Obi L Griffith^*

Washington University School of Medicine, Saint Louis, MO

Sarah Lynn Ondrejka, DO¹, Andrea B. Moffitt^2*, Eric Tse, MBBS, PhD³, Eric D. Hsi, MD⁴, John R. Goodlad, MD^5*, Rex au-Yeung^6*, Yok-Lam Kwong^6*, Gopesh Srivastava^6*, Randy D. Gascoyne⁷, Deepthi Rajagopalan^2*, Cassandra Love^2* and Sandeep Dave, MD⁸

¹Cleveland Clinic, Cleveland, OH
²Duke University, Durham, NC
³Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
⁴Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH
⁵Western General Hospital, Edinburgh, United Kingdom
⁶Hong Kong University, Hong Kong, China
⁷British Columbia Cancer Agency, Centre for Lymphoid Cancer, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
⁸Duke Cancer Institute, Duke University Medical Center, Durham, NC

Maurice Reimann, Dr.^1*, Sven Masswig^1*, Kolja Schleich, Dr.^1*, Andrea Herrmann^1*, Philipp Lohneis, MD^2*, Jens Schrezenmeier^1*, Bernd Dörken, Prof.^1,3* and Clemens Schmitt^1,3

¹Medical Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Charité Universitätsmedizin Berlin, Berlin, Germany
²Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany
³Max-Delbruck Center for Molecular Medicine, Berlin, Germany